SCHEMBL10275697

SCHEMBL10275697

CC1=C(c2ccc(F)cc2F)N2NC(c3ccc(N)cc3)=CC(=O)C2=NC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.34
PDE3A Q14432 4/20 0.34
KLKB1 P03952 3/20 0.33
DYRK1A Q13627 1/20 0.33
TDP2 O95551 1/20 0.33
DHODH Q02127 2/20 0.32
HTR2A P28223 1/20 0.31
GRM2 Q14416 1/20 0.31
FGFR1 P11362 1/20 0.31
ALOX5AP P20292 2/20 0.31
FEN1 P39748 2/20 0.31
HDAC2 Q92769 1/20 0.31
PGR P06401 1/20 0.30
NR3C2 P08235 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
ALDH1A1 P00352 1/20 0.30
DHFR P00374 1/20 0.30
CA1 P00915 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10276045 0.89 APP (0.35) TDP2KDM4EMEN1ALDH1A1HPGD
SCHEMBL10275642 0.88 PDE3B (0.37) PDE3BPDE3ATDP2FGFR1ALOX5AP
SCHEMBL10275483 0.77 ALOX5AP (0.34) PDE3BPDE3ATDP2HTR2AGRM2
SCHEMBL10276009 0.77 PDE3B (0.36) PDE3BPDE3ATDP2HTR2AGRM2
SCHEMBL10275945 0.67 AR (0.34) PDE3BPDE3A
SCHEMBL10275694 0.65 TDP2 (0.35) PDE3BPDE3AKLKB1TDP2HTR2A
SCHEMBL11545227 0.64 TAAR1 (0.50) PDE3BPDE3AKLKB1TDP2GRM2
SCHEMBL10275852 0.61 TDP2 (0.32) TDP2HTR2AGRM2ALOX5APFEN1
SCHEMBL10276613 0.60 PDE3B (0.32) PDE3BPDE3AKLKB1DYRK1ATDP2
SCHEMBL10275939 0.58 PGR (0.39) PDE3BPDE3APGRNR3C2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 PDE3B 2361/4885PDE3A 2182/4885KLKB1 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.